Colchicine compositions and methods

Details Colchicine compositions and methods Colchicine compositions and methods

2011-07-19

2011-07-19

Padmanabhan, Sreeni (Department: 1627)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C564S123000, C564S308000, C564S427000, C568S306000

Reexamination Certificate

active

07981938

ABSTRACT:
Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed.

REFERENCES:
patent: 7601758 (2009-10-01), Davis
patent: 7619004 (2009-11-01), Davis
Wang et al. 2001, HMG-CoA reductase inhibitors (Statins) characterized as direct inhibitors of P-glycoprotein. Pharmaceutical Research, vol. 18, No. 6, pp. 800-806.
Horn et al. 2006, Life-threatening colchicine drug interactions. Pharmacy Times, p. 111.
U.S. Appl. No. 12/372,046, filed Feb. 2009, Davis, Matthew W.
U.S. Appl. No. 12/407,980, filed Mar. 2009, Davis, Matthew W.
U.S. Appl. No. 12/465,210, filed May 2009, Davis, Matthew W.
U.S. Appl. No. 12/688,038, filed Jan. 2010, Davis, Matthew W.
U.S. Appl. No. 12/576,355, filed Oct. 2009, Davis, Matthew W.
U.S. Appl. No. 12/545,120, filed Aug. 2009, Davis, Matthew W.
U.S. Appl. No. 12/489,750, filed Jun. 2009, Davis, Matthew W.
U.S. Appl. No. 12/545,377, filed Aug. 2009, Davis, Matthew W.
U.S. Appl. No. 12/246,034, filed Oct. 2008, Davis, Matthew W.
Jordan, K.M. et al. “British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout (Full Guidelines)”, Rheumatology, 2007, pp. 1-17, Online Supplement to Jordan et al. 2007 “British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout (Executive Summary)”, Rheumatology (Oxford). Aug. 2007;46(8):1372-4. Epub May 23, 2007.
Zhang, W. et al., “EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)”, Ann Rheum Dis 2006, 65: 1312-1324.
Ahern, M.J. et al., “Does Colchicine Work? The results of the first controlled study in acute gout” Aust NZ J Med 1987; 17: 301-304.
Borstad, G.C. et al., “Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis” J Rheumatol 2004; 31: 2429-32.
Terkeltaub, R.A, “Gout”, N.E. J Med 2003, 349: 1647-55.
Paulus, H.E. et al. “Prophylactic colchicine therapy of intercritical gout. A placebo-controlled study of probenecid-treated patients” Arthritis Rheum 1974, 17(5): 609-14.
Probenecid and Colchicine Tablets USP, Mar. 2006, Watson Laboratories product label.
Colchicine Tablets USP, 0.6 mg, Vision Pharma LLC product label, Oct. 2006.
Leikin, J.B. and Paloucek, F.P., eds.; Poisoning and Toxicology Handbook, 4th Ed., CRC Press, Taylor & Francis Group, Informa Healthcare, Aug. 2007, pp. 216-217.
Yu, T.F. & Gutman, A.B., “Efficacy of Colchicine Prophylaxis in Gout: Prevention of Recurrent Gouty Arthritis Over a Mean Period of Five Years in 208 Gouty Subjects”, Ann. Int. Med., Aug. 1961, 55(2): pp. 179-192.
“Abate” entry, Merriam-Webster Online Dictionary, downloaded from http://www.merriam-webster.com/dictionary/abate on Nov. 18, 2010.
Ben-Chetrit, E. et al., Colchicine: 1998 Update, Semin Arthritis Rheum. 1998; 28: 48-59.
FDA Alert issued Jul. 30, 2009, “Information for Healthcare Professionals: New Safety Information for Colchicine (marketed as Colcrys)”, downloaded from the FDA internet website (http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetylnformationforPatientsandProviders/DrugSafetylnformationforHeathcareProfessionals/ucm174315.htm) on Sep. 8, 2010.

Affiliated with

Also associated with

Rating

Colchicine compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Colchicine compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Colchicine compositions and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2667738